Log in

BioXcel Therapeutics SEC Filings & 10K Form (NASDAQ:BTAI)

$24.43
+2.20 (+9.90 %)
(As of 03/29/2020 04:00 PM ET)
Today's Range
$21.00
Now: $24.43
$25.94
50-Day Range
$14.79
MA: $27.30
$41.14
52-Week Range
$3.76
Now: $24.43
$43.63
Volume481,557 shs
Average Volume709,883 shs
Market Capitalization$493.00 million
P/E RatioN/A
Dividend YieldN/A
Beta0.58

SEC Filings

BioXcel Therapeutics (NASDAQ:BTAI) SEC Filings

DateFilerForm TypeView
03/09/2020
8:24 AM
BioXcel Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/09/2020
7:00 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2020
10:13 AM
BioXcel Therapeutics (Subject)
DNCA FINANCE (Filed by)
Form SC 13D/A
02/24/2020
8:30 AM
BioXcel Therapeutics (Subject)
DNCA FINANCE (Filed by)
Form SC 13D/A
02/20/2020
8:54 PM
BioXcel Therapeutics (Filer)
Form 424B5
02/20/2020
8:50 PM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2020
4:22 PM
BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
4:11 PM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2020
4:07 PM
BioXcel Therapeutics (Filer)
Form 424B5
02/18/2020
9:18 AM
BioXcel Therapeutics (Subject)
DNCA FINANCE (Filed by)
Form SC 13D/A
01/13/2020
8:12 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2019
4:06 PM
BioXcel Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/14/2019
8:15 AM
BioXcel Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/14/2019
7:00 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/28/2019
12:42 AM
BioXcel Therapeutics (Filer)
Form 424B5
09/27/2019
4:31 PM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2019
3:58 PM
BioXcel Therapeutics (Filer)
Form 424B5
09/25/2019
3:20 PM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/26/2019
4:38 PM
BioXcel Therapeutics (Issuer)
MUELLER PETER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2019
3:26 PM
BioXcel Therapeutics (Issuer)
MUELLER PETER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2019
3:16 PM
BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2019
3:17 PM
BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2019
3:15 PM
BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2019
3:15 PM
BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2019
8:16 AM
BioXcel Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2019
7:06 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/22/2019
8:29 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/19/2019
8:07 PM
BioXcel Therapeutics (Issuer)
Votruba Michal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2019
4:05 PM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2019
8:01 PM
BioXcel Therapeutics (Issuer)
Laumas Sandeep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2019
8:00 PM
BioXcel Therapeutics (Issuer)
MUELLER PETER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2019
7:59 PM
BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2019
5:10 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2019
8:28 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2019
8:18 AM
BioXcel Therapeutics (Filer)
Form 424B5
05/20/2019
8:04 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2019
7:17 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2019
11:16 PM
BioXcel Therapeutics (Filer)
Form EFFECT
04/01/2019
4:30 PM
BioXcel Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/01/2019
4:20 PM
BioXcel Therapeutics (Filer)
Form DEF 14A
04/01/2019
4:15 PM
BioXcel Therapeutics (Filer)
Form RW
03/25/2019
3:45 PM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2019
4:38 PM
BioXcel Therapeutics (Issuer)
Votruba Michal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2019
4:35 PM
BioXcel Therapeutics (Issuer)
Votruba Michal (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/14/2019
3:45 PM
BioXcel Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/12/2019
4:21 PM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2019
3:38 PM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2019
3:42 PM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2019
3:19 PM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
6:33 AM
BioXcel Corp (Filed by)
BioXcel Therapeutics (Subject)
Form SC 13G
02/04/2019
4:03 PM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2019
3:27 PM
BioXcel Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
12/27/2018
3:11 PM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2018
4:08 PM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2018
10:56 AM
BioXcel Therapeutics (Filer)
Form CT ORDER
12/14/2018
3:30 PM
BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2018
3:11 PM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2018
8:05 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/07/2018
4:50 PM
BioXcel Therapeutics (Issuer)
MUELLER PETER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2018
4:34 PM
BioXcel Therapeutics (Issuer)
MUELLER PETER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2018
5:04 AM
BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2018
4:05 PM
BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2018
9:22 AM
BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2018
8:49 AM
BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2018
4:36 PM
BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2018
4:35 PM
BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2018
3:17 PM
BioXcel Therapeutics (Issuer)
Nandabalan Krishnan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2018
3:10 PM
BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2018
1:31 PM
BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2018
1:30 PM
BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2018
7:44 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2018
6:47 AM
BioXcel Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/09/2018
6:35 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2018
3:30 PM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2018
7:15 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2018
3:20 PM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2018
9:06 AM
BioXcel Therapeutics (Subject)
DNCA FINANCE (Filed by)
Form SC 13D
08/23/2018
4:09 PM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2018
3:13 PM
BioXcel Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2018
3:02 PM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2018
4:20 PM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2018
3:17 PM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2018
3:01 PM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2018
3:59 PM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2018
3:20 PM
BioXcel Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2018
3:19 PM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2018
3:12 PM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2018
9:11 AM
BioXcel Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G
03/13/2018
4:13 PM
BioXcel Therapeutics (Issuer)
Laumas Sandeep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2018
4:12 PM
BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2018
4:12 PM
BioXcel Therapeutics (Issuer)
MUELLER PETER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2018
4:11 PM
BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2018
4:10 PM
BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2018
2:35 PM
BioXcel Therapeutics (Filer)
Form 424B4
03/08/2018
12:10 PM
BioXcel Therapeutics (Filer)
Form CT ORDER
03/07/2018
11:15 PM
BioXcel Therapeutics (Filer)
Form EFFECT
03/07/2018
5:35 PM
BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/07/2018
5:27 PM
BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/07/2018
5:26 PM
BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/07/2018
5:25 PM
BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
This page was last updated on 3/29/2020 by MarketBeat.com Staff

Featured Article: Closed-End Mutual Funds

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel